Myocardial preconditioning using adenosine: Review and clinical experience

Perfusion

Volumn 13, Issue 2, 1998, Pages 145-149

  Zarro, Debra L ^a   Palanzo, David A ^a   Sadr, Farrokh S ^a  

^a LEHIGH VALLEY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE;

ADULT; AGED; AORTA ROOT; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; HEART FUNCTION; HEART SURGERY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; REPERFUSION INJURY; RETROSPECTIVE STUDY;

EID: 0031885449     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765919801300201     Document Type: Article

References (15)

1. Lee HT, Rocco JL, Reed GE. Pretreatment of human myocardium with adenosine during open heart surgery. J Card Surg 1995; 10: 665-76.
2. Bolling SF, Bies LE, Gallagher KP, Bove EL. Enhanced myocardial protection with adenosine. Ann Thorac Surg 1989; 47: 809-15.
3. 1 adenosine receptors in rabbit heart. Circulation 1991; 84: 350-56.
4. 1-selective adenosine analogues protects the heart against infarction. Circulation 1992; 85: 659-65.
5. Toombs, CF, McGee S, Johnston, WE et al. Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation 1992; 86: 986-94.
6. Reimer KA, Hill ML, Jennings RB. Prolonged depletion of ATP and the adenosine nucleotide pool due to delayed resynthesis of adenosine nucleotides following reversible myocardial ischemic injury in dogs. J Mol Cell Cardiol 1981; 13: 229-39.
7. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning of the human myocardium. Lancet 1993; 343: 276-7.
8. Bunch FT, Thornton, J, Cohen, MV, Downey JM. Adenosine is an endogenous protectant against repetitive ischemic episodes in the heart. Am Heart J 1992; 124: 1440-46.
9. Ikonomidis JS, Weisel RD, Mickle DAG. Ischemic preconditioning: cardiac protection for cardiac surgery. J Cardiac Surg 1994; 9(suppl): 526-31.
10. Tsuchida A, Miura T, Miki T et al. Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning. Cardiovasc Res 1992; 26: 456-61.
11. Lawson CS, Downey JM. Preconditioning: state of the art myocardial protection. Cardiovasc Res 1993; 27: 542-50.
12. Gatell JA, Barner HB, Shevde K. Adenosine and myocardial protection. J Cardiothorac Vasc Anesth 1997; 7: 466-80.
13. Belardinelli L, Linden J, Berne RM. The cardiac effects of adenosine. Prog Cardiovasc Dis 1989; 32: 73-97.
14. Jovanovi A, Alekseev AE, López JR, Shen WK, Terzic A. Adenosine prevents hyperkalemic-induced calcium loading in cardiac cells: relevance for cardioplegia. Ann Thorac Surg 1997; 63: 153-61.
15. Todd J, Zhao ZQ, Williams MW, Sato H, Van Wylen DGL, Vinten-Johansen J. Intravascular adenosine at reperfusion reduces infarct size and neutrophil adherence. Ann Thorac Surg 1996; 62: 1364-72.